Airway mucus, inflammation and remodeling: emerging links in the pathogenesis of chronic lung diseases

Cell and Tissue Research

Volumn 367, Issue 3, 2017, Pages 537-550

  Zhou Suckow, Zhe ^a   Duerr, Julia ^a   Hagner, Matthias ^a   Mall, Marcus A ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Airway epithelium; Airway inflammation; Airway mucus; Allergic asthma; Chronic obstructive pulmonary disease (COPD); Cystic fibrosis (CF); Epithelial ion transport; Mucociliary clearance (MCC)

Indexed keywords

ALLERGEN; CIGARETTE SMOKE; EPITHELIAL SODIUM CHANNEL;

AIRWAY MUCUS OBSTRUCTION; AIRWAY OBSTRUCTION; AIRWAY REMODELING; BRONCHUS MUCUS; CHRONIC LUNG DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; HUMAN; IMMUNOMODULATION; LUNG INJURY; MUCOCILIARY CLEARANCE; MUCUS SECRETION; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; RESPIRATORY TRACT ALLERGY; RESPIRATORY TRACT INFECTION; RESPIRATORY TRACT INFLAMMATION; REVIEW; TRACHEA MUCUS; ANIMAL; CHRONIC DISEASE; COMPLICATION; INFLAMMATION; LUNG; LUNG DISEASE; METABOLISM; MUCUS; PATHOLOGY; PATHOPHYSIOLOGY;

AIRWAY REMODELING; ANIMALS; CHRONIC DISEASE; HUMANS; INFLAMMATION; LUNG; LUNG DISEASES; MUCUS;

EID: 85009858733     PISSN: 0302766X     EISSN: 14320878     Source Type: Journal    
DOI: 10.1007/s00441-016-2562-z     Document Type: Review

References (136)

1. Adkins B, Leclerc C, Marshall-Clarke S (2004) Neonatal adaptive immunity comes of age. Nat Rev Immunol 4:553–564
2. Anagnostopoulou P, Dai L, Schatterny J, Hirtz S, Duerr J, Mall MA (2010) Allergic airway inflammation induces a pro-secretory epithelial ion transport phenotype in mice. Eur Respir J 36:1436–1447
3. Anagnostopoulou P, Riederer B, Duerr J, Michel S, Binia A, Agrawal R, Liu X, Kalitzki K, Xiao F, Chen M, Schatterny J, Hartmann D, Thum T, Kabesch M, Soleimani M, Seidler U, Mall MA (2012) SLC26A9-mediated chloride secretion prevents mucus obstruction in airway inflammation. J Clin Invest 122:3629–3634
4. Anderson WH, Coakley RD, Button B, Henderson AG, Zeman KL, Alexis NE, Peden DB, Lazarowski ER, Davis CW, Bailey S, Fuller F, Almond M, Qaqish B, Bordonali E, Rubinstein M, Bennett WD, Kesimer M, Boucher RC (2015) The relationship of mucus concentration (Hydration) to mucus osmotic pressure and transport in chronic bronchitis. Am J Respir Crit Care Med 192:182–190
5. Bakouh N, Bienvenu T, Thomas A, Ehrenfeld J, Liote H, Roussel D, Duquesnoy P, Farman N, Viel M, Cherif-Zahar B, Amselem S, Taam RA, Edelman A, Planelles G, Sermet-Gaudelus I (2013) Characterization of SLC26A9 in patients with CF-like lung disease. Hum Mutat 34:1404–1414
6. Bateman JR, Pavia D, Sheahan NF, Agnew JE, Clarke SW (1983) Impaired tracheobronchial clearance in patients with mild stable asthma. Thorax 38:463–467
7. Baum GL, Zwas ST, Katz I, Roth Y (1990) Mucociliary clearance from central airways in patients with excessive sputum production with and without primary ciliary dyskinesia. Chest 98:608–612
8. Becq F, Mall MA, Sheppard DN, Conese M, Zegarra-Moran O (2011) Pharmacological therapy for cystic fibrosis: from bench to bedside. J Cyst Fibros 10(Suppl 2):S129–S145
9. Bertrand CA, Zhang R, Pilewski JM, Frizzell RA (2009) SLC26A9 is a constitutively active, CFTR-regulated anion conductance in human bronchial epithelia. J Gen Physiol 133:421–438
10. Birket SE, Chu KK, Liu L, Houser GH, Diephuis BJ, Wilsterman EJ, Dierksen G, Mazur M, Shastry S, Li Y, Watson JD, Smith AT, Schuster BS, Hanes J, Grizzle WE, Sorscher EJ, Tearney GJ, Rowe SM (2014) A functional anatomic defect of the cystic fibrosis airway. Am J Respir Crit Care Med 190:421–432
11. Bonora M, Riffault L, Marie S, Mall M, Clement A, Tabary O (2011) Morphological analysis of the trachea and pattern of breathing in betaENaC-Tg mice. Respir Physiol Neurobiol 178:346–348
12. Bonser LR, Zlock L, Finkbeiner W, Erle DJ (2016) Epithelial tethering of MUC5AC-rich mucus impairs mucociliary transport in asthma. J Clin Invest 126:2367–2371
13. Boucher RC (2007) Cystic fibrosis: a disease of vulnerability to airway surface dehydration. Trends Mol Med 13:231–240
14. Boucher RC, Stutts MJ, Knowles MR, Cantley L, Gatzy JT (1986) Na+ transport in cystic fibrosis respiratory epithelia. abnormal basal rate and response to adenylate cyclase activation. J Clin Invest 78:1245–1252
15. Button B, Cai LH, Ehre C, Kesimer M, Hill DB, Sheehan JK, Boucher RC, Rubinstein M (2012) A periciliary brush promotes the lung health by separating the mucus layer from airway epithelia. Science 337:937–941
16. Button B, Anderson WH, Boucher RC (2016) Mucus hyperconcentration as a unifying aspect of the chronic bronchitic phenotype. Ann Am Thorac Soc 13(Suppl 2):S156–S162
17. Byers DE, Holtzman MJ (2011) Alternatively activated macrophages and airway disease. Chest 140:768–774
18. Byrne AJ, Mathie SA, Gregory LG, Lloyd CM (2015) Pulmonary macrophages: key players in the innate defence of the airways. Thorax 70:1189–1196
19. Cantin AM, Hanrahan JW, Bilodeau G, Ellis L, Dupuis A, Liao J, Zielenski J, Durie P (2006) Cystic fibrosis transmembrane conductance regulator function is suppressed in cigarette smokers. Am J Respir Crit Care Med 173:1139–1144
20. Cantin AM, Hartl D, Konstan MW, Chmiel JF (2015) Inflammation in cystic fibrosis lung disease: pathogenesis and therapy. J Cyst Fibros 14:419–430
21. Chen CJ, Kono H, Golenbock D, Reed G, Akira S, Rock KL (2007) Identification of a key pathway required for the sterile inflammatory response triggered by dying cells. Nat Med 13:851–856
22. Chen Y, Garvin LM, Nickola TJ, Watson AM, Colberg-Poley AM, Rose MC (2014) IL-1beta induction of MUC5AC gene expression is mediated by CREB and NF-kappaB and repressed by dexamethasone. Am J Physiol Lung Cell Mol Physiol 306:L797–L807
23. Churg A, Wright JL (2005) Proteases and emphysema. Curr Opin Pulm Med 11:153–159
24. Clunes LA, Davies CM, Coakley RD, Aleksandrov AA, Henderson AG, Zeman KL, Worthington EN, Gentzsch M, Kreda SM, Cholon D, Bennett WD, Riordan JR, Boucher RC, Tarran R (2012) Cigarette smoke exposure induces CFTR internalization and insolubility, leading to airway surface liquid dehydration. FASEB J 26:533–545
25. Cobos-Correa A, Trojanek JB, Diemer S, Mall MA, Schultz C (2009) Membrane-bound FRET probe visualizes MMP12 activity in pulmonary inflammation. Nat Chem Biol 5:628–630
26. De Boeck K, Amaral MD (2016) Progress in therapies for cystic fibrosis. Lancet Respir Med 4:662–674
27. Dinarello CA, Simon A, van der Meer JW (2012) Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases. Nat Rev Drug Discov 11:633–652
28. Donaldson SH, Corcoran TE, Laube BL, Bennett WD (2007) Mucociliary clearance as an outcome measure for cystic fibrosis clinical research. Proc Am Thorac Soc 4:399–405
29. Doring G, Bragonzi A, Paroni M, Akturk FF, Cigana C, Schmidt A, Gilpin D, Heyder S, Born T, Smaczny C, Kohlhaufl M, Wagner TO, Loebinger MR, Bilton D, Tunney MM, Elborn JS, Pier GB, Konstan MW, Ulrich M (2014) BIIL 284 reduces neutrophil numbers but increases P. aeruginosa bacteremia and inflammation in mouse lungs. J Cyst Fibros 13:156–163
30. Dransfield MT, Wilhelm AM, Flanagan B, Courville C, Tidwell SL, Raju SV, Gaggar A, Steele C, Tang LP, Liu B, Rowe SM (2013) Acquired CFTR dysfunction in the lower airways in COPD. Chest 144:498–506
31. Evans CM, Kim K, Tuvim MJ, Dickey BF (2009) Mucus hypersecretion in asthma: causes and effects. Curr Opin Pulm Med 15:4–11
32. Evans CM, Raclawska DS, Ttofali F, Liptzin DR, Fletcher AA, Harper DN, McGing MA, McElwee MM, Williams OW, Sanchez E, Roy MG, Kindrachuk KN, Wynn TA, Eltzschig HK, Blackburn MR, Tuvim MJ, Janssen WJ, Schwartz DA, Dickey BF (2015) The polymeric mucin Muc5ac is required for allergic airway hyperreactivity. Nat Commun 6:6281
33. Fahy JV (2015) Type 2 inflammation in asthma--present in most, absent in many. Nat Rev Immunol 15:57–65
34. Fahy JV, Dickey BF (2010) Airway mucus function and dysfunction. N Engl J Med 363:2233–2247
35. Fellner RC, Terryah ST, Tarran R (2016) Inhaled protein/peptide-based therapies for respiratory disease. Mol Cell Pediatr 3:16
36. Fritzsching B, Zhou-Suckow Z, Trojanek JB, Schubert SC, Schatterny J, Hirtz S, Agrawal R, Muley T, Kahn N, Sticht C, Gunkel N, Welte T, Randell SH, Langer F, Schnabel P, Herth FJ, Mall MA (2015) Hypoxic epithelial necrosis triggers neutrophilic inflammation via IL-1 receptor signaling in cystic fibrosis lung disease. Am J Respir Crit Care Med 191:902–913
37. Fritzsching B, Hagner M, Dai L, Christochowitz S, Agrawal R., Van Bodegom C, Schmidt S, Schatterny J, Hirtz S, Brown R, Goritzka M, Duerr J, Zhou-Suckow Z, Mall MA (2016) Impaired mucus clearance exacerbates allergen-induced type 2 airway inflammation in juvenile mice. J Allergy Clin Immunol. doi: 10.1016/j.jaci.2016.09.045
38. Fujisawa T, Chang MM, Velichko S, Thai P, Hung LY, Huang F, Phuong N, Chen Y, Wu R (2011) NF-kappaB mediates IL-1beta- and IL-17A-induced MUC5B expression in airway epithelial cells. Am J Respir Cell Mol Biol 45:246–252
39. Gaggar A, Hector A, Bratcher PE, Mall MA, Griese M, Hartl D (2011) The role of matrix metalloproteinases in cystic fibrosis lung disease. Eur Respir J 38:721–727
40. Galluzzo M, Ciraolo E, Lucattelli M, Hoxha E, Ulrich M, Campa CC, Lungarella G, Doring G, Zhou-Suckow Z, Mall M, Hirsch E, De RV (2015) Genetic deletion and pharmacological inhibition of PI3K gamma reduces neutrophilic airway inflammation and lung damage in mice with cystic fibrosis-like lung disease. Mediators Inflamm 2015:545417
41. Gehrig S, Mall MA, Schultz C (2012) Spatially resolved monitoring of neutrophil elastase activity with ratiometric fluorescent reporters. Angew Chem Int Ed Engl 51:6258–6261
42. Gehrig S, Duerr J, Weitnauer M, Wagner CJ, Graeber SY, Schatterny J, Hirtz S, Belaaouaj A, Dalpke AH, Schultz C, Mall MA (2014) Lack of neutrophil elastase reduces inflammation, mucus hypersecretion, and emphysema, but not mucus obstruction, in mice with cystic fibrosis-like lung disease. Am J Respir Crit Care Med 189:1082–1092
43. Geiser M, Quaile O, Wenk A, Wigge C, Eigeldinger-Berthou S, Hirn S, Schaffler M, Schleh C, Moller W, Mall MA, Kreyling WG (2013) Cellular uptake and localization of inhaled gold nanoparticles in lungs of mice with chronic obstructive pulmonary disease. Part Fibre Toxicol 10:19
44. Geiser M, Wigge C, Conrad ML, Eigeldinger-Berthou S, Kunzi L, Garn H, Renz H, Mall MA (2014) Nanoparticle uptake by airway phagocytes after fungal spore challenge in murine allergic asthma and chronic bronchitis. BMC Pulm Med 14:116
45. Ghosh A, Boucher RC, Tarran R (2015) Airway hydration and COPD. Cell Mol Life Sci 72:3637–3652
46. Gibson RL, Burns JL, Ramsey BW (2003) Pathophysiology and management of pulmonary infections in cystic fibrosis. Am J Respir Crit Care Med 168:918–951
47. Gordon S, Martinez FO (2010) Alternative activation of macrophages: mechanism and functions. Immunity 32:593–604
48. Graeber SY, Zhou-Suckow Z, Schatterny J, Hirtz S, Boucher RC, Mall MA (2013) Hypertonic saline is effective in the prevention and treatment of mucus obstruction, but not airway inflammation, in mice with chronic obstructive lung disease. Am J Respir Cell Mol Biol 49:410–417
49. Gustafsson JK, Ermund A, Ambort D, Johansson ME, Nilsson HE, Thorell K, Hebert H, Sjovall H, Hansson GC (2012) Bicarbonate and functional CFTR channel are required for proper mucin secretion and link cystic fibrosis with its mucus phenotype. J Exp Med 209:1263–1272
50. Hammad H, Lambrecht BN (2015) Barrier epithelial cells and the control of Type 2 immunity. Immunity 43:29–40
51. Hartl D, Gaggar A, Bruscia E, Hector A, Marcos V, Jung A, Greene C, McElvaney G, Mall M, Doring G (2012) Innate immunity in cystic fibrosis lung disease. J Cyst Fibros 11:363–382
52. Hautamaki RD, Kobayashi DK, Senior RM, Shapiro SD (1997) Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. Science 277:2002–2004
53. Hays SR, Fahy JV (2003) The role of mucus in fatal asthma. Am J Med 115:68–69
54. Hector A, Kormann MS, Mack I, Latzin P, Casaulta C, Kieninger E, Zhou Z, Yildirim AO, Bohla A, Rieber N, Kappler M, Koller B, Eber E, Eickmeier O, Zielen S, Eickelberg O, Griese M, Mall MA, Hartl D (2011) The Chitinase-like protein YKL-40 modulates cystic fibrosis lung disease. PLoS ONE 6:e24399
55. Henderson AG, Ehre C, Button B, Abdullah LH, Cai LH, Leigh MW, DeMaria GC, Matsui H, Donaldson SH, Davis CW, Sheehan JK, Boucher RC, Kesimer M (2014) Cystic fibrosis airway secretions exhibit mucin hyperconcentration and increased osmotic pressure. J Clin Invest 124:3047–3060
56. Hiemstra PS, McCray PB Jr, Bals R (2015) The innate immune function of airway epithelial cells in inflammatory lung disease. Eur Respir J 45:1150–1162
57. Hoegger MJ, Fischer AJ, McMenimen JD, Ostedgaard LS, Tucker AJ, Awadalla MA, Moninger TO, Michalski AS, Hoffman EA, Zabner J, Stoltz DA, Welsh MJ (2014) Impaired mucus detachment disrupts mucociliary transport in a piglet model of cystic fibrosis. Science 345:818–822
58. Hogg JC (2004) Pathophysiology of airflow limitation in chronic obstructive pulmonary disease. Lancet 364:709–721
59. Hogg JC, Timens W (2009) The pathology of chronic obstructive pulmonary disease. Annu Rev Pathol 4:435–459
60. Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, Buzatu L, Cherniack RM, Rogers RM, Sciurba FC, Coxson HO, Pare PD (2004) The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 350:2645–2653
61. Houtmeyers E, Gosselink R, Gayan-Ramirez G, Decramer M (1999) Effects of drugs on mucus clearance. Eur Respir J 14:452–467
62. Hu HY, Gehrig S, Reither G, Subramanian D, Mall MA, Plettenburg O, Schultz C (2014) FRET-based and other fluorescent proteinase probes. Biotechnol J 9:266–281
63. Jaecklin T, Duerr J, Huang H, Rafii M, Bear CE, Ratjen F, Pencharz P, Kavanagh BP, Mall MA, Grasemann H (2014) Lung arginase expression and activity is increased in cystic fibrosis mouse models. J Appl Physiol 117(1985):284–288
64. Janssen WJ, Stefanski AL, Bochner BS, Evans CM (2016) Control of lung defence by mucins and macrophages: ancient defence mechanisms with modern functions. Eur Respir J 48:1201–1214
65. Jia J, Conlon TM, Ballester LC, Seimetz M, Bednorz M, Zhou-Suckow Z, Weissmann N, Eickelberg O, Mall MA, Yildirim AO (2016) Cigarette smoke causes acute airway disease and exacerbates chronic obstructive lung disease in neonatal mice. Am J Physiol Lung Cell Mol Physiol 311:L602–L610
66. Johannesson B, Hirtz S, Schatterny J, Schultz C, Mall MA (2012) CFTR regulates early pathogenesis of chronic obstructive lung disease in bENaC-overexpressing mice. PLoS ONE 7:e44059
67. Knowles MR, Boucher RC (2002) Mucus clearance as a primary innate defense mechanism for mammalian airways. J Clin Invest 109:571–577
68. Kopp BT, Sarzynski L, Khalfoun S, Hayes D Jr, Thompson R, Nicholson L, Long F, Castile R, Groner J (2015) Detrimental effects of secondhand smoke exposure on infants with cystic fibrosis. Pediatr Pulmonol 50:25–34
69. Kuyper LM, Pare PD, Hogg JC, Lambert RK, Ionescu D, Woods R, Bai TR (2003) Characterization of airway plugging in fatal asthma. Am J Med 115:6–11
70. Landgraf-Rauf K, Anselm B, Schaub B (2016) The puzzle of immune phenotypes of childhood asthma. Mol Cell Pediatr 3:27
71. Lewis CC, Aronow B, Hutton J, Santeliz J, Dienger K, Herman N, Finkelman FD, Wills-Karp M (2009) Unique and overlapping gene expression patterns driven by IL-4 and IL-13 in the mouse lung. J Allergy Clin Immunol 123:795–804
72. Livraghi A, Grubb BR, Hudson EJ, Wilkinson KJ, Sheehan JK, Mall MA, O’Neal WK, Boucher RC, Randell SH (2009) Airway and lung pathology due to mucosal surface dehydration in b-epithelial Na + channel-overexpressing mice: role of TNF-a and IL-4Ra signaling, influence of neonatal development, and limited efficacy of glucocorticoid treatment. J Immunol 182:4357–4367
73. Livraghi-Butrico A, Kelly EJ, Klem ER, Dang H, Wolfgang MC, Boucher RC, Randell SH, O’Neal WK (2012) Mucus clearance, MyD88-dependent and MyD88-independent immunity modulate lung susceptibility to spontaneous bacterial infection and inflammation. Mucosal Immunol 5:397–408
74. Livraghi-Butrico A, Grubb BR, Wilkinson KJ, Volmer AS, Burns KA, Evans CM, O’Neal WK, Boucher RC (2016) Contribution of mucus concentration and secreted mucins Muc5ac and Muc5b to the pathogenesis of muco-obstructive lung disease. Mucosal Immunol (in press)
75. Lloyd CM, Saglani S (2015) Epithelial cytokines and pulmonary allergic inflammation. Curr Opin Immunol 34:52–58. doi:10.1016/j.coi.2015.02.001
76. Locke LW, Myerburg MM, Weiner DJ, Markovetz MR, Parker RS, Muthukrishnan A, Weber L, Czachowski MR, Lacy RT, Pilewski JM, Corcoran TE (2016) Pseudomonas infection and mucociliary and absorptive clearance in the cystic fibrosis lung. Eur Respir J 47:1392–1401
77. Lohi H, Kujala M, Makela S, Lehtonen E, Kestila M, Saarialho-Kere U, Markovich D, Kere J (2002) Functional characterization of three novel tissue-specific anion exchangers SLC26A7, -A8, and -A9. J Biol Chem 277:14246–14254
78. Lukens JR, Gross JM, Kanneganti TD (2012) IL-1 family cytokines trigger sterile inflammatory disease. Front Immunol 3:315
79. Mack I, Hector A, Ballbach M, Kohlhaufl J, Fuchs KJ, Weber A, Mall MA, Hartl D (2015) The role of chitin, chitinases, and chitinase-like proteins in pediatric lung diseases. Mol Cell Pediatr 2:3–0014
80. Majno G, Joris I (1995) Apoptosis, oncosis, and necrosis. an overview of cell death. Am J Pathol 146:3–15
81. Mall MA (2008) Role of cilia, mucus, and airway surface liquid in mucociliary dysfunction: lessons from mouse models. J Aerosol Med Pulm Drug Deliv 21:13–24
82. Mall MA (2009) Role of the amiloride-sensitive epithelial Na + channel in the pathogenesis and as a therapeutic target for cystic fibrosis lung disease. Exp Physiol 94:171–174
83. Mall MA (2016) Unplugging mucus in cystic fibrosis and chronic obstructive pulmonary disease. Ann Am Thorac Soc 13(Suppl 2):S177–S185. doi:10.1513/AnnalsATS.201509-641KV.:S177-S185
84. Mall MA, Galietta LJ (2015) Targeting ion channels in cystic fibrosis. J Cyst Fibros 14:561–570
85. Mall MA, Hartl D (2014) CFTR: cystic fibrosis and beyond. Eur Respir J 44:1042–1054
86. + conductance is reduced by CFTR in normal but not in cystic fibrosis airways. J Clin Invest 102:15–21
87. + absorption produces cystic fibrosis-like lung disease in mice. Nat Med 10:487–493
88. + channel-overexpressing mice. Am J Respir Crit Care Med 177:730–742
89. Mall MA, Button B, Johannesson B, Zhou Z, Livraghi A, Caldwell RA, Schubert SC, Schultz C, O’Neal WK, Pradervand S, Hummler E, Rossier BC, Grubb BR, Boucher RC (2010) Airway surface liquid volume regulation determines different airway phenotypes in liddle compared with betaENaC-overexpressing mice. J Biol Chem 285:26945–26955
90. Mall MA, Graeber SY, Stahl M, Zhou-Suckow Z (2014) Early cystic fibrosis lung disease: role of airway surface dehydration and lessons from preventive rehydration therapies in mice. Int J Biochem Cell Biol 52:174–179
91. Mall MA, Stahl M, Graeber SY, Sommerburg O, Kauczor HU, Wielputz MO (2016) Early detection and sensitive monitoring of CF lung disease: prospects of improved and safer imaging. Pediatr Pulmonol 51:S49–S60
92. Marcos V, Zhou-Suckow Z, Onder YA, Bohla A, Hector A, Vitkov L, Krautgartner WD, Stoiber W, Griese M, Eickelberg O, Mall MA, Hartl D (2015) Free DNA in cystic fibrosis airway fluids correlates with airflow obstruction. Mediators Inflamm 2015:408935
93. McCarthy C, Reeves EP, McElvaney NG (2016) The role of neutrophils in Alpha-1 antitrypsin deficiency. Ann Am Thorac Soc 13(Suppl 4):S297–S304
94. Pavia D, Bateman JR, Sheahan NF, Agnew JE, Clarke SW (1985) Tracheobronchial mucociliary clearance in asthma: impairment during remission. Thorax 40:171–175
95. Quinton PM (2008) Cystic fibrosis: impaired bicarbonate secretion and mucoviscidosis. Lancet 372:415–417
96. Raclawska DS, Ttofali F, Fletcher AA, Harper DN, Bochner BS, Janssen WJ, Evans CM (2016) Mucins and their sugars. critical mediators of hyperreactivity and inflammation. Ann Am Thorac Soc 13(Suppl 1):S98–S99
97. Regnis JA, Robinson M, Bailey DL, Cook P, Hooper P, Chan HK, Gonda I, Bautovich G, Bye PT (1994) Mucociliary clearance in patients with cystic fibrosis and in normal subjects. Am J Respir Crit Care Med 150:66–71
98. Rose MC, Voynow JA (2006) Respiratory tract mucin genes and mucin glycoproteins in health and disease. Physiol Rev 86:245–278
99. Rowan SA, Bradley JM, Bradbury I, Lawson J, Lynch T, Gustafsson P, Horsley A, O’Neill K, Ennis M, Elborn JS (2014) Lung clearance index is a repeatable and sensitive indicator of radiological changes in bronchiectasis. Am J Respir Crit Care Med 189:586–592
100. Roy MG, Livraghi-Butrico A, Fletcher AA, McElwee MM, Evans SE, Boerner RM, Alexander SN, Bellinghausen LK, Song AS, Petrova YM, Tuvim MJ, Adachi R, Romo I, Bordt AS, Bowden MG, Sisson JH, Woodruff PG, Thornton DJ, Rousseau K, De la Garza MM, Moghaddam SJ, Karmouty-Quintana H, Blackburn MR, Drouin SM, Davis CW, Terrell KA, Grubb BR, O’Neal WK, Flores SC, Cota-Gomez A, Lozupone CA, Donnelly JM, Watson AM, Hennessy CE, Keith RC, Yang IV, Barthel L, Henson PM, Janssen WJ, Schwartz DA, Boucher RC, Dickey BF, Evans CM (2014) Muc5b is required for airway defence. Nature 505:412–416
101. Sagel SD, Wagner BD, Anthony MM, Emmett P, Zemanick ET (2012) Sputum biomarkers of inflammation and lung function decline in children with cystic fibrosis. Am J Respir Crit Care Med 186:857–865
102. Saglani S, Mathie SA, Gregory LG, Bell MJ, Bush A, Lloyd CM (2009) Pathophysiological features of asthma develop in parallel in house dust mite-exposed neonatal mice. Am J Respir Cell Mol Biol 41:281–289
103. Saini Y, Dang H, Livraghi-Butrico A, Kelly EJ, Jones LC, O’Neal WK, Boucher RC (2014) Gene expression in whole lung and pulmonary macrophages reflects the dynamic pathology associated with airway surface dehydration. BMC Genomics 15:726
104. Saini Y, Wilkinson KJ, Terrell KA, Burns KA, Livraghi-Butrico A, Doerschuk CM, O’Neal WK, Boucher RC (2015) Neonatal pulmonary macrophage depletion coupled to defective mucus clearance increases susceptibility to pneumonia and alters pulmonary immune responses. Am J Respir Cell Mol Biol 54:210–221
105. Salomon JJ, Spahn S, Wang X, Fullekrug J, Bertrand CA, Mall MA (2016) Generation and functional characterization of epithelial cells with stable expression of SLC26A9 Cl- channels. Am J Physiol Lung Cell Mol Physiol 310:L593–L602
106. Schmitz J, Owyang A, Oldham E, Song Y, Murphy E, McClanahan TK, Zurawski G, Moshrefi M, Qin J, Li X, Gorman DM, Bazan JF, Kastelein RA (2005) IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 23:479–490
107. Seys LJ, Verhamme FM, Dupont LL, Desauter E, Duerr J, Seyhan AA, Conickx G, Joos GF, Brusselle GG, Mall MA, Bracke KR (2015) Airway surface dehydration aggravates cigarette smoke-induced hallmarks of COPD in mice. PLoS ONE 10:e0129897
108. Shipley JM, Wesselschmidt RL, Kobayashi DK, Ley TJ, Shapiro SD (1996) Metalloelastase is required for macrophage-mediated proteolysis and matrix invasion in mice. Proc Natl Acad Sci U S A 93:3942–3946
109. Sly PD, Brennan S, Gangell C, de Klerk N, Murray C, Mott L, Stick SM, Robinson PJ, Robertson CF, Ranganathan SC (2009) Lung disease at diagnosis in infants with cystic fibrosis detected by newborn screening. Am J Respir Crit Care Med 180:146–152
110. Sly PD, Gangell CL, Chen L, Ware RS, Ranganathan S, Mott LS, Murray CP, Stick SM (2013) Risk factors for bronchiectasis in children with cystic fibrosis. N Engl J Med 368:1963–1970
111. Smaldone GC, Foster WM, O’Riordan TG, Messina MS, Perry RJ, Langenback EG (1993) Regional impairment of mucociliary clearance in chronic obstructive pulmonary disease. Chest 103:1390–1396
112. Snodgrass AM, Tan PT, Soh SE, Goh A, Shek LP, van Bever HP, Gluckman PD, Godfrey KM, Chong YS, Saw SM, Kwek K, Teoh OH (2015) Tobacco smoke exposure and respiratory morbidity in young children. Tob Control 25(e2):e75–e82
113. Solomon GM, Marshall SG, Ramsey BW, Rowe SM (2015) Breakthrough therapies: Cystic fibrosis (CF) potentiators and correctors. Pediatr Pulmonol 50(Suppl 40):S3–S13
114. Solomon GM, Raju SV, Dransfield MT, Rowe SM (2016) Therapeutic approaches to acquired cystic fibrosis transmembrane conductance regulator dysfunction in chronic bronchitis. Ann Am Thorac Soc 13(Suppl 2):S169–S176
115. Stahl M, Wielputz MO, Graeber SY, Joachim C, Sommerburg O, Kauczor HU, Puderbach M, Eichinger M, Mall MA (2016) Comparison of lung clearance index and magnetic resonance imaging for assessment of lung disease in children with cystic fibrosis. Am J Respir Crit Care Med doi:10.1164/rccm.201604-0893OC
116. Stahr CS, Samarage CR, Donnelley M, Farrow N, Morgan KS, Zosky G, Boucher RC, Siu KK, Mall MA, Parsons DW, Dubsky S, Fouras A (2016) Quantification of heterogeneity in lung disease with image-based pulmonary function testing. Sci Rep 6:29438
117. Stanojevic S, Ratjen F (2016) Physiologic endpoints for clinical studies for cystic fibrosis. J Cyst Fibros 15:416–423
118. Strug LJ, Gonska T, He G, Keenan K, Ip W, Boelle PY, Lin F, Panjwani N, Gong J, Li W, Soave D, Xiao B, Tullis E, Rabin H, Parkins MD, Price A, Zuberbuhler PC, Corvol H, Ratjen F, Sun L, Bear CE, Rommens JM (2016) Cystic fibrosis gene modifier SLC26A9 modulates airway response to CFTR-directed therapeutics. Hum Mol Genet (in press)
119. Sun L, Rommens JM, Corvol H, Li W, Li X, Chiang TA, Lin F, Dorfman R, Busson PF, Parekh RV, Zelenika D, Blackman SM, Corey M, Doshi VK, Henderson L, Naughton KM, O’Neal WK, Pace RG, Stonebraker JR, Wood SD, Wright FA, Zielenski J, Clement A, Drumm ML, Boelle PY, Cutting GR, Knowles MR, Durie PR, Strug LJ (2012) Multiple apical plasma membrane constituents are associated with susceptibility to meconium ileus in individuals with cystic fibrosis. Nat Genet 44:562–569
120. Trojanek JB, Cobos-Correa A, Diemer S, Kormann M, Schubert SC, Zhou-Suckow Z, Agrawal R, Duerr J, Wagner CJ, Schatterny J, Hirtz S, Sommerburg O, Hartl D, Schultz C, Mall MA (2014) Airway mucus obstruction triggers macrophage activation and matrix metalloproteinase 12-dependent emphysema. Am J Respir Cell Mol Biol 51:709–720
121. Twigg MS, Brockbank S, Lowry P, FitzGerald SP, Taggart C, Weldon S (2015) The role of serine proteases and antiproteases in the cystic fibrosis lung. Mediators Inflamm 2015:293053. doi:10.1155/2015/293053
122. Vastag E, Matthys H, Zsamboki G, Kohler D, Daikeler G (1986) Mucociliary clearance in smokers. Eur J Respir Dis 68:107–113
123. Vestbo J, Hurd SS, Agusti AG, Jones PW, Vogelmeier C, Anzueto A, Barnes PJ, Fabbri LM, Martinez FJ, Nishimura M, Stockley RA, Sin DD, Rodriguez-Roisin R (2013) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 187:347–365
124. Wagner CJ, Schultz C, Mall MA (2016) Neutrophil elastase and matrix metalloproteinase 12 in cystic fibrosis lung disease. Mol Cell Pediatr 3:25
125. Wanner A, Salathe M, O’Riordan TG (1996) Mucociliary clearance in the airways. Am J Respir Crit Care Med 154:1868–1902
126. Wielpütz MO, Mall MA (2015) Imaging modalities in cystic fibrosis: emerging role of MRI. Curr Opin Pulm Med 21:609–616
127. Wielpütz MO, Eichinger M, Zhou Z, Leotta K, Hirtz S, Bartling SH, Semmler W, Kauczor HU, Puderbach M, Mall MA (2011) In vivo monitoring of cystic fibrosis-like lung disease in mice by volumetric computed tomography. Eur Respir J 38:1060–1070
128. Wielputz MO, Puderbach M, Kopp-Schneider A, Stahl M, Fritzsching E, Sommerburg O, Ley S, Sumkauskaite M, Biederer J, Kauczor HU, Eichinger M, Mall MA (2014) Magnetic resonance imaging detects changes in structure and perfusion, and response to therapy in early cystic fibrosis lung disease. Am J Respir Crit Care Med 189:956–965
129. Wills-Karp M, Luyimbazi J, Xu X, Schofield B, Neben TY, Karp CL, Donaldson DD (1998) Interleukin-13: central mediator of allergic asthma. Science 282:2258–2261
130. Yuan S, Hollinger M, Lachowicz-Scroggins ME, Kerr SC, Dunican EM, Daniel BM, Ghosh S, Erzurum SC, Willard B, Hazen SL, Huang X, Carrington SD, Oscarson S, Fahy JV (2015) Oxidation increases mucin polymer cross-links to stiffen airway mucus gels. Sci Transl Med 7:276ra27
131. Zegarra-Moran O, Galietta LJ (2016) CFTR pharmacology. Cell Mol Life Sci (in press)
132. Zheng T, Zhu Z, Wang Z, Homer RJ, Ma B, Riese RJ Jr, Chapman HA Jr, Shapiro SD, Elias JA (2000) Inducible targeting of IL-13 to the adult lung causes matrix metalloproteinase- and cathepsin-dependent emphysema. J Clin Invest 106:1081–1093
133. Zhou Z, Treis D, Schubert SC, Harm M, Schatterny J, Hirtz S, Duerr J, Boucher RC, Mall MA (2008) Preventive but not late amiloride therapy reduces morbidity and mortality of lung disease in bENaC-overexpressing mice. Am J Respir Crit Care Med 178:1245–1256
134. Zhou Z, Duerr J, Johannesson B, Schubert SC, Treis D, Harm M, Graeber SY, Dalpke A, Schultz C, Mall MA (2011) The bENaC-overexpressing mouse as a model of cystic fibrosis lung disease. J Cyst Fibros 10(Suppl 2):S172–S182
135. Zhu Z, Homer RJ, Wang Z, Chen Q, Geba GP, Wang J, Zhang Y, Elias JA (1999) Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J Clin Invest 103:779–788
136. Zuelzer WW, Newton WA (1949) The pathogenesis of fibrocystic disease of the pancreas; a study of 36 cases with special reference to the pulmonary lesions. Pediatrics 4:53–69